AssetMark Inc
CME icon

AssetMark Inc’s CME Group CME Stock Holding History

AssetMark Inc’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.35M Sell
33,281
-362
-1% -$100K 0.01% 629
2026
Q1 		$9.94M Sell
33,643
-1,614
-5% -$479K 0.02% 507
2025
Q4 		$9.63M Buy
35,257
+9,366
+36% +$2.55M 0.02% 505
2025
Q3 		$7M Sell
25,891
-8,253
-24% -$2.25M 0.02% 553
2025
Q2 		$9.41M Buy
34,144
+9,063
+36% +$2.46M 0.02% 421
2025
Q1 		$6.65M Buy
25,081
+1,004
+4% +$248K 0.02% 440
2024
Q4 		$5.59M Sell
24,077
-48
-0.2% -$11K 0.02% 479
2024
Q3 		$5.32M Buy
24,125
+1,249
+5% +$258K 0.02% 442
2024
Q2 		$4.5M Buy
22,876
+5,858
+34% +$1.21M 0.01% 453
2024
Q1 		$3.66M Buy
17,018
+1,959
+13% +$412K 0.01% 471
2023
Q4 		$3.17M Buy
15,059
+2,180
+17% +$465K 0.01% 464
2023
Q3 		$2.58M Buy
12,879
+1,758
+16% +$349K 0.01% 463
2023
Q2 		$2.06M Buy
11,121
+846
+8% +$156K 0.01% 470
2023
Q1 		$1.97M Buy
10,275
+1,464
+17% +$265K 0.01% 455
2022
Q4 		$1.48M Buy
8,811
+96
+1% +$16.7K 0.01% 488
2022
Q3 		$1.54M Buy
8,715
+1,324
+18% +$262K 0.01% 429
2022
Q2 		$1.51M Buy
7,391
+837
+13% +$177K 0.01% 412
2022
Q1 		$1.56M Buy
6,554
+2,592
+65% +$609K 0.01% 392
2021
Q4 		$905K Buy
3,962
+1,925
+95% +$424K ﹤0.01% 422
2021
Q3 		$394K Buy
2,037
+367
+22% +$74.4K ﹤0.01% 484
2021
Q2 		$355K Buy
1,670
+101
+6% +$21.3K ﹤0.01% 501
2021
Q1 		$320K Sell
1,569
-49,769
-97% -$9.8M ﹤0.01% 498
2020
Q4 		$9.35M Sell
51,338
-4,207
-8% -$715K 0.05% 216
2020
Q3 		$9.29M Sell
55,545
-50,041
-47% -$8.43M 0.06% 200
2020
Q2 		$17.6M Sell
105,586
-4,247
-4% -$761K 0.13% 152
2020
Q1 		$19M Sell
109,833
-35,966
-25% -$7.16M 0.16% 119
2019
Q4 		$29.3M Buy
145,799
+29,869
+26% +$6.13M 0.22% 113
2019
Q3 		$24.5M Buy
115,930
+721
+0.6% +$151K 0.21% 108
2019
Q2 		$22.4M Buy
115,209
+111,113
+2,713% +$20.5M 0.18% 117
2019
Q1 		$674K Sell
4,096
-289
-7% -$51.1K 0.01% 316
2018
Q4 		$825K Buy
4,385
+3,372
+333% +$623K 0.01% 293
2018
Q3 		$172K Buy
1,013
+72
+8% +$12.1K ﹤0.01% 478
2018
Q2 		$154K Buy
941
+34
+4% +$5.55K ﹤0.01% 489
2018
Q1 		$147K Sell
907
-288
-24% -$45.8K ﹤0.01% 493
2017
Q4 		$175K Buy
1,195
+117
+11% +$16.7K ﹤0.01% 489
2017
Q3 		$146K Sell
1,078
-101
-9% -$12.8K ﹤0.01% 513
2017
Q2 		$148K Sell
1,179
-244
-17% -$29.2K ﹤0.01% 487
2017
Q1 		$169K Buy
1,423
+19
+1% +$2.29K ﹤0.01% 441
2016
Q4 		$162K Sell
1,404
-400
-22% -$44.5K ﹤0.01% 430
2016
Q3 		$189K Sell
1,804
-79,110
-98% -$8.26M ﹤0.01% 401
2016
Q2 		$7.88M Buy
80,914
+8,387
+12% +$793K 0.13% 135
2016
Q1 		$6.97M Buy
72,527
+10,726
+17% +$976K 0.12% 131
2015
Q4 		$5.6M Buy
61,801
+10,502
+20% +$988K 0.1% 142
2015
Q3 		$4.76M Buy
51,299
+51,125
+29,382% +$4.86M 0.1% 131
2015
Q2 		$16K Buy
+174
New +$16.2K ﹤0.01% 479

Other funds holding CME

PAM
PineStone Asset Management Montreal, Quebec, Canada $16.2B AUM 25.74% 1-Year Est. Return
SP
Sarasin & Partners London, United Kingdom $8.54B AUM 9.6% 1-Year Est. Return
RG
Rathbones Group Liverpool, United Kingdom $27.1B AUM 20.2% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
GAM
Guinness Asset Management London, United Kingdom $5.91B AUM 21.44% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $71.2B AUM 41.74% 1-Year Est. Return
SLAM
Swiss Life Asset Management Zurich $24.1B AUM 38.82% 1-Year Est. Return
HCM
Hamlin Capital Management New York $4.45B AUM 22.95% 1-Year Est. Return
JSSH
J. Safra Sarasin Holding $6.97B AUM 32.91% 1-Year Est. Return
CF
Canoe Financial Calgary, Alberta, Canada $8.07B AUM 25.47% 1-Year Est. Return

AssetMark Inc's CME Position: Q2 2026 in Review

AssetMark Inc reduced its CME Group (CME) stake by 1.1% in Q2 2026, selling an estimated $100K and leaving 33,281 shares worth $7.35M. The position accounts for 0.01% of the portfolio, ranked #629.

AssetMark Inc first reported a position in CME in Q2 2015 and has held it in 45 quarters since. The position peaked at $29.3M in Q4 2019. 670 funds tracked by Wall St. Rank hold CME as of Q2 2026.

  • AssetMark Inc held 33,281 shares of CME Group worth $7.35M as of Q2 2026.
  • AssetMark Inc sold 362 CME Group shares in Q2 2026, an estimated $100K.
  • CME Group made up 0.01% of AssetMark Inc's portfolio in Q2 2026, its #629 holding.
  • AssetMark Inc first reported a position in CME Group in Q2 2015 and has held it in 45 quarters since.
  • AssetMark Inc's CME Group position peaked at $29.3M in Q4 2019.
  • 670 funds tracked by Wall St. Rank held CME Group as of Q2 2026.

Based on AssetMark Inc's 13F filing for Q2 2026, filed 30 Jul 2026.